Journal
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
Volume 26, Issue 7, Pages 1579-1585Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1161/01.ATV.0000221231.56617.67
Keywords
phospholipase; atherogenesis; inflammation; lipoprotein-retention; proteoglycans
Categories
Ask authors/readers for more resources
Objective - To study the distribution of group V secretory phospholipase A(2) (sPLA(2)) in human and mouse lesions and compare its expression by human vascular cells, its activity toward lipoproteins, and the interaction with arterial proteoglycans (proteoglycans) with those of sPLA(2)-IIA. In addition, we also investigated the effect of a Western diet and lipopolysaccharide challenge on the aortic expression of these enzymes in mouse models. Methods and Results - Immunohistochemistry showed sPLA(2)-V in human and mouse lesions to be associated with smooth muscle cells and also surrounding foam cells in lipid core areas. mRNA of the enzyme was expressed in human lesions and human vascular cells, supporting the immunohistochemistry data. sPLA(2)-V but not sPLA(2)-IIA was active on lipoproteins in human serum. The association with proteoglycans enhanced 2- to 3-fold sPLA(2)-V activity toward low-density lipoproteins but not that of the group IIA enzyme. Experiments in mouse models showed that treatment with a Western diet induced expression of sPLA(2)-V but not that of sPLA(2)-IIA in aorta. On the other hand, lipopolysaccharide-induced acute inflammation augmented the expression of sPLA(2)-IIA but not that of sPLA(2)-V. Conclusions - These results indicate that these phospholipases could have different roles in atherosclerosis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available